By continuing to use the site you agree to our Privacy & Cookies policy

Six-monthly monitoring of HbA1c may be too frequent for diabetes patients

Six-monthly monitoring of HbA1c among some patients with type 2 diabetes may be too frequent and cause unnecessary treatment changes, according to a study published by NHS Diabetes and Oxford University.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units